Von Willebrand factor propeptide makes it easy to identify the shorter Von Willebrand factor survival in patients with type 1 and type Vicenza von Willebrand disease

British Journal of Haematology

Volumn 143, Issue 1, 2008, Pages 107-114

  Sztukowska, M ^a   Gallinaro, L ^a   Cattini, M G ^a   Pontara, E ^a   Sartorello, F ^a   Daidone, V ^a   Padrini, R ^a   Pagnan, A ^a   Casonato, A ^a,b  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Type Vicenza VWD; Von Willebrand disease; Von Willebrand factor; VWF propeptide ratio; VWF survival

Indexed keywords

DESMOPRESSIN; VON WILLEBRAND FACTOR;

ARTICLE; BLOOD GROUP; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; GENE MUTATION; HUMAN; MISSENSE MUTATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SURVIVAL RATE; VICENZA VON WILLEBRAND DISEASE; VON WILLEBRAND DISEASE;

CASE-CONTROL STUDIES; DEAMINO ARGININE VASOPRESSIN; DNA MUTATIONAL ANALYSIS; HALF-LIFE; HEMOSTATICS; HUMANS; MUTATION; PROTEIN PRECURSORS; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 51249123703     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07311.x     Document Type: Article

References (28)

1. Bloom, A.L., Giddings, J.C. Wilks, C.J. (1973) Factor VIII on the vascular intima: possible importance in haemostasis and thrombosis. Nature, 241, 217 219.
2. Borchiellini, A., Fijnvandraat, K., ten Cate, J.W., Pajkrt, D., van Deventer, S.J., Pasterkamp, G., Meijer-Huizinga, F., Zwart-Huinink, L., Voorberg, J. van Mourik, J.A. (1996) Quantitative analysis of von Willbrand factor propeptide release in vivo: effect of experimental endotoxemia and administration of 1-deamino-8-D-arginine vasopressin in humans. Blood, 88, 2951 2958.
3. Brown, S.A., Eldrige, A., Collins, P.W. Bowen, D.J. (2003) Increased clearance of von Willebrand factor antigen post-DDAVP in type 1 von Willebrand disease: is it a potential pathogenic process? Journal of Thrombosis and Haemostasis, 1, 1714 1717.
4. Casonato, A., Sartori, M.T., Pontara, E., Zucchetto, S. Girolami, A. (1992) Impaired release of tissue plasminogen activator (t-PA) following DDAVP infusion in von Willebrand's disease with low platelet von Willebrand factor content. Blood Coagulation & Fibrinolysis, 3, 149 153.
5. Casonato, A., Pontara, E., Sartorello, F., Cattini, M.G., Sartori, M.T., Padrini, R. Girolami, A. (2002) Reduced von Willebrand factor survival in type Vicenza von Willebrand disease. Blood, 99, 180 184.
6. Casonato, A., Sartorello, F., Cattini, M.G., Pontara, E., Soldera, C., Bertomoro, A. Girolami, A. (2003) An Arg760Cys mutation in the consensus sequence of the von Willebrand factor propeptide cleavage site is responsible for a new von Willebrand disease variant. Blood, 101, 151 156.
7. Casonato, A., Pontara, E., Sartorello, F., Cattini, M.G., Gallinaro, L., Bertomoro, A., Rosato, A., Padrini, R. Pagnan, A. (2006) Identifying type Vicenza von Willebrand disease. Journal of Laboratory and Clinical Medicine, 147, 96 102.
8. Casonato, A., De Marco, L., Gallinaro, L., Sztukowska, M., Mazzuccato, M., Battiston, M., Pagnan, A. Ruggeri, Z.M. (2007) Altered von Willebrand factor subunit proteolysis and multimer processing associated with the Cys2362Phe mutation in the B2 domain. Thrombosis and Haemostasis, 97, 527 533.
9. Castaman, G., Lethagen, S., Federici, A.B., Tosetto, A., Goodeve, A., Budde, U., Batlle, J., Meyer, D., Mazurier, C., Fressinaud, E., Goudemand, J., Eikenboom, J., Schneppenheim, R., Ingerslev, J., Vorlova, Z., Habart, D., Holmberg, L., Pasi, J., Hill, F., Peake, I. Rodeghiero, F. (2008) Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD. Blood, 111, 3531 3539.
10. Gallinaro, L., Sartorello, F., Pontara, E., Cattini, M.G., Bertomoro, A., Bartoloni, L., Pagnan, A. Casonato, A. (2006) Combined partial exon skipping and cryptic splice site activation as a new molecular mechanism for recessive type 1 von Willebrand disease. Thrombosis and Haemostasis, 96, 711 716.
11. Gallinaro, L., Cattini, M.G., Sztukowska, M., Padrini, R., Sartorello, F., Pontara, E., Bertomoro, A., Daidone, V., Pagnan, A. Casonato, A. (2008) Shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor. Blood, 111, 3540 3545.
12. Gibaldi, M. Perrier, D. (1975) Pharrmacokinetics. Marcel Dekker, New York, NY.
13. Goodeve, A.C., Eikenboom, J.C., Ginsburg, D., Hilbert, L., Mazurier, C., Peake, I.R., Sadler, J.E., Rodeghiero, F. ISTH SSC Subcommittee on von Willebrand factor (2001) A standard nomenclature for von Willebrand factor gene mutations and polymorphisms. On behalf of the ISTH SSC Subcommittee on von Willebrand factor. Thrombosis and Haemostasis, 85, 929 931.
14. Haberichter, S.L., Balistreri, M., Christopherson, P., Morateck, P., Gavazova, S., Bellissimo, D.B., Manco-Johnson, M.J., Gill, J.C. Montgomery, R.R. (2006) Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival. Blood, 108, 3344 3351.
15. Haberichter, S.L., Castaman, G., Budde, U., Peake, I., Goodeve, A., Rodeghiero, F., Federici, A.B., Batlle, J., Meyer, D., Mazurier, C., Goudemand, J., Eikenboom, J., Schneppenheim, R., Ingerslev, J., Vorlova, Z., Habart, D., Holmberg, L., Lethagen, S., Pasi, J., Hill, F.G. Montgomery, R.R. (2008) Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD). Blood, 111, 4979 4985.
16. Hannah, M.J., Williams, R., Kaur, J., Hewlett, L.J. Cutler, D.F. (2002) Biogenesis of Weibel-Palade bodies. Seminars in Cell & Developmental Biology, 13, 313 324.
17. Lenting, P.J., Westein, E., Terraube, V., Ribba, A.S., Huizinga, E.G., Meyer, D., de Groot, P.G. Denis, C.V. (2004) An experimental model to study the in vivo survival of von Willebrand factor. Journal of Biological Chemistry, 279, 12102 12109.
18. Mancuso, D.J., Tuley, E.A., Westfield, L.A., Worrall, N.K., Shelton-Inloes, B.B., Sorace, J.M., Alevy, Y.G. Sadler, J.E. (1989) Structure of the gene for human von Willebrand factor. Journal of Biological Chemistry, 264, 19514 19527.
19. Michiels, J.J., van de Velde, A., van Vliet, H.H.D.M., van der Planken, M., Schroyens, W. Berneman, Z. (2002) Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 von Willebrand disease: diagnostic and therapeutic implications. Seminars in Thrombosis and Hemostasis, 28, 111 132.
20. Nachman, R.L., Levine, R. Jaffe, E.A. (1977) Synthesis of Factor VIII antigen by cultured guinea pig megakaryocytes. Journal of Clinical Investigation, 60, 914 921.
21. Sadler, J.E. (2006) Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. Journal of Thrombosis and Haemostasis, 4, 2103 2114.
22. Van Schooten, C.J., Tjernberg, P., Westein, E., Terraube, V., Castaman, G., Mourik, J.A., Hollestelle, M.J., Vos, H.L., Bertina, R.M., Berg, H.M., Eikenboom, J.C., Lenting, P.J. Denis, C.V. (2005) Cysteine mutations in von Willebrand factor associated with increased clearance. Journal of Thrombosis and Haemostasis, 3, 2228 2237.
23. Visher, U.M. Wagner, D.D. (1994) Von Willebrand proteolytic processing and multimerization precede the formation of Weibel-Palade bodies. Blood, 83, 3536 3544.
24. Voorberg, J., Fontijn, R., van-Mourik, J.A. Pannekoek, H. (1990) Domains involved in multimer assembly of von Willebrand factor (vWF): multimerization is independent of dimerization. EMBO Journal, 9, 797 803.
25. Voorberg, J., Fontijn, R., Calafat, J., Janssen, H., van Mourik, J.A. Pannekoek, H. (1991) Assembly and routing of von Willebrand factor variants: the requirements for disulfide-linked dimerization reside within the carboxy-terminal-151 amino acids. The Journal of Cell Biology, 113, 195 205.
26. Wagner, D.D. (1990) Cell biology of von Willebrand factor. Annual Review of Cell Biology, 6, 217 246.
27. Wagner, D.D. Marder, V.J. (1984) Biosynthesis of von Willebrand factor protein by human endothelial cells: processing steps and their intracellular localization. Journal of Cell Biology, 99, 2123 2130.
28. Wagner, D.D., Mayadas, T. Marder, V.J. (1986) Initial glycosylation and acidic pH in the Golgi apparatus are required for multimerization of von Willebrand factor. The Journal of Cell Biology, 102, 1320 1324.